Significant strides in pediatric chemotherapy have transformed the outlook for children diagnosed with cancer. Over the past few decades, advances in drug formulation, treatment protocols, and supportive care have contributed to improved survival rates and better quality of life for young patients.
Pediatric chemo advances focus on delivering effective treatment while minimizing long-term side effects that can impact growth, development, and overall health. Innovations such as targeted therapies, reduced-toxicity regimens, and risk-adapted treatment plans are helping clinicians personalize care based on the child’s specific cancer type and genetic profile.